AKT2 - AKT serine/threonine kinase 2 Gene

Macaca mulatta

Gene ID: 700591 | Gene type: protein coding

About AKT2

Primary_assembly 19: 39,438,173-39,489,584 reverse strand.Mmul_10:CM014354.1

This gene has 10 transcripts (splice variants), 237 orthologues and 6 paralogues.

mRNA	Protein	Name
NM_001265989.1	NP_001252918.1	RAC-beta serine/threonine-protein kinase

PH_PKB

STKc_PKB_beta

Protein Preferred Names

Protein Names

RAC-beta serine/threonine-protein kinase

Approval

Bioactive Molecules (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0960	Sulfabenzamide		99.68%	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99118	Serplulimab	Inducer	99.30%	Unkown

Clinical Phase

Bioactive Molecules (17)

Cat. No.	Product Name	Effect	Purity	Phase
HY-15186	Ipatasertib	Inhibitor	99.88%	Phase 4
HY-N0004	Oridonin	Inhibitor	99.89%	Phase 4
HY-15431	Capivasertib	Inhibitor	99.96%	Phase 3
HY-15727	Afuresertib	Inhibitor	99.53%	Phase 3
HY-15186A	Ipatasertib dihydrochloride	Inhibitor	99.27%	Phase 3
HY-19719	Miransertib	Inhibitor	99.32%	Phase 2
HY-15965	Uprosertib	Inhibitor	99.93%	Phase 2
HY-19934A	Pifusertib hydrochloride	Inhibitor	99.90%	Phase 2
HY-15727A	Afuresertib hydrochloride	Inhibitor	99.95%	Phase 2
HY-19719A	Miransertib hydrochloride	Inhibitor	99.74%	Phase 2
HY-19934	Pifusertib	Inhibitor	99.81%	Phase 2
HY-15965A	Uprosertib hydrochloride	Inhibitor	/	Phase 2
HY-10358	MK-2206 dihydrochloride	Inhibitor	99.99%	Phase 1
HY-10249	GSK-690693	Inhibitor	99.03%	Phase 1
HY-100018	BAY1125976	Inhibitor	99.52%	Phase 1
HY-16071	AT13148	Inhibitor	99.20%	Phase 1
HY-15186C	Ipatasertib tosylate	Inhibitor	/	Phase 1

Pre-clinical Phase

Bioactive Molecules (26)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10355	AKT inhibitor VIII	Inhibitor	98.97%	Unkown
HY-108232	MK-2206	Inhibitor	99.72%	Unkown
HY-10425	Rizavasertib	Inhibitor	99.71%	Unkown
HY-133120	INY-03-041	Inhibitor	99.74%	Unkown
HY-13260	CCT128930	Inhibitor	99.69%	Unkown
HY-151504	Engasertib	Inhibitor	99.65%	Unkown
HY-12059	AT7867	Inhibitor	99.85%	Unkown
HY-137458A	Vevorisertib trihydrochloride	Inhibitor	99.13%	Unkown
HY-19982	AKT-IN-6	Inhibitor	99.08%	Unkown
HY-145282	MS170	Inhibitor	98.68%	Unkown
HY-12059A	AT7867 dihydrochloride	Inhibitor	99.73%	Unkown
HY-50862	Akt1/Akt2-IN-1	Inhibitor	99.30%	Unkown
HY-137458	Vevorisertib	Inhibitor	98.03%	Unkown
HY-133120A	INY-03-041 trihydrochloride	Inhibitor	99.78%	Unkown
HY-132302	Hu7691	Inhibitor	99.91%	Unkown
HY-16666	3CAI	Inhibitor	98.32%	Unkown
HY-13260A	CCT128930 hydrochloride	Inhibitor	98.97%	Unkown
HY-129119	Akt1/Akt2-IN-2	Inhibitor	98.57%	Unkown
HY-151613	MS15	Inhibitor	/	Unkown
HY-126257	AKT-IN-3	Inhibitor	98.12%	Unkown
HY-145281	MS98	Inhibitor	/	Unkown
HY-132302A	Hu7691 free base	Inhibitor	/	Unkown
HY-10357	MK-2206 free base	Inhibitor	/	Unkown
HY-138767	AKT-IN-5	Inhibitor	/	Unkown
HY-143611	AKT-IN-8	Inhibitor	/	Unkown
HY-16032	Akt1-IN-2	Inhibitor	/	Unkown

Species	Symbol	Source	ID
Homo sapiens	AKT2	NCBI	NCBI:208
Mus musculus	AKT2	NCBI	NCBI:11652

Name
Email *

	Sorry, but the email address you supplied was invalid.